首页 | 本学科首页   官方微博 | 高级检索  
检索        

洛伐他汀与依那普利对慢性肾脏疾病蛋白尿的影响
引用本文:潘慧娟,霍光.洛伐他汀与依那普利对慢性肾脏疾病蛋白尿的影响[J].医学理论与实践,2007,20(2):141-142.
作者姓名:潘慧娟  霍光
作者单位:广东省深圳市南山区西丽人民医院内科,518055
摘    要:目的:探讨洛伐他汀与依那普利治疗对慢性肾脏疾病的作用。方法:选择2002年1月~2006年2月门诊及住院的非糖尿病的58例慢性肾脏疾病患者随机分为治疗组和对照组。对照组给予常规治疗,其中包括每天口服依那普利5mg,2次/d,治疗组在上述治疗的基础上每晚加服20mg洛伐他汀。比较两组治疗前及治疗后3、6个月的血糖、血压、尿蛋白定量(Upr)、血肌酐(Scr)等指标。结果:两组治疗后较治疗前Upr和Scr均明显下降(P<0.05),治疗组Upr和Scr下降比对照组明显(P<0.05,P<0.01)。结论:对于慢性肾脏疾病患者,ACEI与他汀类药物联用,可以更好地达到保护肾脏的目的。

关 键 词:依那普利  洛伐他汀  蛋白尿  慢性肾脏疾病
文章编号:1001-7585(2007)02-0141-02
收稿时间:2006-07-28
修稿时间:2006年7月28日

Effects of the Combination of Enalapril and Lovastatin on Albuminuria in Patients with Chronic Kidney Disease
PAN Huijuan,HUO Guang.Effects of the Combination of Enalapril and Lovastatin on Albuminuria in Patients with Chronic Kidney Disease[J].The Journal of Medical Theory and Practice,2007,20(2):141-142.
Authors:PAN Huijuan  HUO Guang
Abstract:Objective: To investigate the therapeutic effects of combination of enalapril and lovastatin on the chronic kidney disease(CKD).Methods: 58 patients with CKD were randomly divided into two groups,the controlled group received conventional therapy(including 5 microgram of enalapril,bid,PO),while the treated group was added orally 20 microgram of lovastatin every night.The blood glucose,blood pressure,Upr and Scr in the patients of two groups were compared before treatment and 3 and 6 months after treatment.Results:Upr and Scr decreased more significantly after therapy in both groups than that before(P<0.05).While they decreased more significantly in treated group than that in control group(P<0.05,P<0.01).Conclusion: ACEI in combination with statin may show more protective effects for patients with chronic kidney disease.
Keywords:Enalapril  Lovastatin  Albuminuria  Chronic kidney disease
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号